Athelas (Drug Delivery) Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Athelas (Drug Delivery) General Information

Description

Operator of an antibacterial target technology development firm intended for the identification of molecules that prevent bacteria from becoming harmful. The company's technology uses amoebae to measure the virulence of bacteria and allows scientists to systematically screen bacteria for their damaging potential. and can then move on to test the bacteria's reaction to chemical compounds, raising the possibility that they will be able to identify new classes of mechanistic agents to fight infectious diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 18, Chemin Des Aulx
  • 1228 Plan-les-Ouates
  • Switzerland
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 18, Chemin Des Aulx
  • 1228 Plan-les-Ouates
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Athelas (Drug Delivery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 21-Aug-2006 Completed Startup
2. Early Stage VC (Series A) 02-Dec-2002 Completed Startup
1. University Spin-Out 01-Jan-2002 Completed Startup
To view Athelas (Drug Delivery)’s complete valuation and funding history, request access »

Athelas (Drug Delivery) Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aravis Growth/Expansion Minority
Angel (individual) Minority
Novartis Venture Fund Corporate Venture Capital Minority
Vi Partners Venture Capital Minority
To view Athelas (Drug Delivery)’s complete investors history, request access »

Athelas (Drug Delivery) FAQs

  • When was Athelas (Drug Delivery) founded?

    Athelas (Drug Delivery) was founded in 2002.

  • Where is Athelas (Drug Delivery) headquartered?

    Athelas (Drug Delivery) is headquartered in Plan-les-Ouates, Switzerland.

  • What industry is Athelas (Drug Delivery) in?

    Athelas (Drug Delivery)’s primary industry is Drug Discovery.

  • Is Athelas (Drug Delivery) a private or public company?

    Athelas (Drug Delivery) is a Private company.

  • What is Athelas (Drug Delivery)’s current revenue?

    The current revenue for Athelas (Drug Delivery) is .

  • How much funding has Athelas (Drug Delivery) raised over time?

    Athelas (Drug Delivery) has raised $1.4M.

  • Who are Athelas (Drug Delivery)’s investors?

    Aravis, , Novartis Venture Fund, and Vi Partners have invested in Athelas (Drug Delivery).

  • When was Athelas (Drug Delivery) acquired?

    Athelas (Drug Delivery) was acquired on 21-Aug-2006.

  • Who acquired Athelas (Drug Delivery)?

    Athelas (Drug Delivery) was acquired by MerLion Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process